Pediatric to Adult Hydrocephalus: A Smooth Transition

Manilyn A Hong1, Arvind Sukumaran1, Jay Riva-Cambrin1

  • 1Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.

Neurology India
|February 1, 2022
PubMed

Insights

Transitioning pediatric hydrocephalus patients to adult care requires addressing patient, provider, and system barriers. Early planning and tailored policies are crucial for successful lifelong management of this chronic neurological condition.

Area of Science:

  • Neurosurgery
  • Pediatric Neurology
  • Healthcare Transition

Background:

  • Pediatric hydrocephalus patients need lifelong care for disease and treatment sequelae.
  • Seamless transition from pediatric to adult healthcare is a significant challenge for neurosurgeons.

Purpose of the Study:

  • To review literature on transitioning pediatric patients with chronic conditions to adult care.
  • To identify barriers and successful models for hydrocephalus patients transitioning to adult neurosurgical care.

Main Methods:

  • Literature review focusing on pediatric chronic condition transition and hydrocephalus-specific transition challenges.
  • Analysis of barriers and essential elements for successful transition policies.

Main Results:

  • Identified barriers include patient, cultural, provider, and healthcare system factors.
  • Six key elements for successful transitions were identified: policy, tracking, readiness, planning, transfer, and completion.
  • Transition success is center-specific, influenced by resources and environment.

Conclusions:

  • Transition policies must be tailored to individual healthcare settings, especially in resource-poor environments.
  • Recommendations include early transition initiation, ideally by age 14.
  • A structured approach is vital for lifelong hydrocephalus management.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
21
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
11
Anatomy of the Brain: Ventricles01:18

Anatomy of the Brain: Ventricles

There are hollow fluid-filled cavities known as ventricles deep inside the human brain. There are two lateral ventricles, one in each cerebral hemisphere, and each has three different projections — the anterior, inferior, and posterior horns visible from the lateral side. A thin membrane called the septum pellucidum separates the two lateral ventricles. The slender third ventricle in the diencephalon is connected to each lateral ventricle via a channel called the interventricular foramen.
5.5K